Compile Data Set for Download or QSAR
maximum 50k data
Found 24 of ph data with Target = 'Sepiapterin reductase'
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50:  12nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50:  19nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  64nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50:  69nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  84nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50:  86nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50:  310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  330nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  340nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50:  360nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50:  400nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50:  1.00E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50:  1.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50:  1.60E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50:  2.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50:  2.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50:  2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50:  2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50:  3.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50:  3.40E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSepiapterin reductase(Homo sapiens (Human))
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50:  4.50E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent